The effect of dental pulp mesenchymal stem cells in treatment of corona disease

Study the effect of intravenous injection of dental pulp mesenchymal stem cells in treatment of patients with COVID-19 pneumonia

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20140911019125N6

Enrollment

Registered

2020-04-04

Start date

2020-04-04

Completion date

Unknown

Last updated

2020-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Corona virus disease. COVID19, virus identified

Interventions

Intervention group: The extracted tooth is brought to the lab . After tooth extraction, it is enzymatically digested and cultured. After the cells have reached the required level, 40 million cells ar

Eligibility

Sex/Gender

All

Age

18 Years to 95 Years

Inclusion criteria

Inclusion criteria: Patients aged between 18-95 years Patients Approved for Covirus 19 by Laboratory Methods

Exclusion criteria

Exclusion criteria: Patients undergoing other clinical trials Patients with standard and routin treatments show progress in clinical signs

Design outcomes

Primary

Measure	Time frame
Pulmonary Condition. Timepoint: Before intervention and 14, 28 days after intervention. Method of measurement: CT scan.;Expression of nucleic acid of virus. Timepoint: Before intervention and 14 and 28 days after intervention. Method of measurement: real time PCR.;Lymphocytes count. Timepoint: Before intervention and 14 and 28 days after intervention. Method of measurement: Flowcytometry.;Patients clinical signs. Timepoint: before intervention and 14 and 28 days after intervention. Method of measurement: Observation.	—

Measure

Time frame

Pulmonary Condition. Timepoint: Before intervention and 14, 28 days after intervention. Method of measurement: CT scan.;Expression of nucleic acid of virus. Timepoint: Before intervention and 14 and 28 days after intervention. Method of measurement: real time PCR.;Lymphocytes count. Timepoint: Before intervention and 14 and 28 days after intervention. Method of measurement: Flowcytometry.;Patients clinical signs. Timepoint: before intervention and 14 and 28 days after intervention. Method of measurement: Observation.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAlireza Farsinejad

Kerman University of Medical Sciences

afarsinejad@kmu.ac.ir+98 34 3132 5374

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026